We narrowed to 591 results for: ARL

1. Improving Transduction Efficiency with Exosome AAVs

   Type

   Blog Post

   ...to neutralizing anti-AAV antibodies. This is particularly useful for therapeutic applications in vivo ...

2. Addgene-Seeding Labs plasmid grant round 3: microbial drug resistance and biofilms, antidiabetic plant components, visualizing brain injury - and a glowing robot fish

   Type

   Blog Post

   ...tuberculosis) and in identifying new drug targets. An early and accurate detection of PZA-resistance is necessary...

3. Unique and persistent IDs for improved reproducibility: Addgene now supports RRIDs and compact identifiers for all plasmids

   Type

   Blog Post

   ...unique PID is the Digital Object Identifier (DOI). Nearly all the papers or preprints you read or produce...

4. Choosing Your Fluorescent Proteins for Multi-Color Imaging

   Type

   Blog Post

   ...contain all fluorescent proteins in common use (particularly not the most recently published ones), they ...

5. Finding and Joining Your Dream Lab

   Type

   Blog Post

   ...Alternatively, perhaps the lab publishes and presents regularly with labs around the world. You may prefer a more...

6. Plasmids 101: Mammalian Vectors

   Type

   Blog Post

   .... Positive selection in mammalian cells works similarly to that in bacteria and a table of the most commonly...

7. OCaMP: A New Calcium Indicator for Neural Imaging

   Type

   Blog Post

   ...Scientists have developed calcium indicators spanning nearly the entire visible spectrum (Figure 1). The GCaMP...

8. Plasmids 101: Sequence and Ligation Independent Cloning (SLIC)

   Type

   Blog Post

   ...researchers doing large amounts of cloning. Assembly is scarless, unlike Gateway cloning, and the method’s flexibility...

9. Viral Vectors 101: Types of viruses

   Type

   Blog Post

   ...to specific cell types of interest. This is a particularly nice feature as organ-specific injections, or...

10. Viral Vectors 101: The AAV Retrograde Serotype

    Type

    Blog Post

    ...these vectors can exhibit spurious expression, particularly at the injection site (Fischer, KB. 2019). The...

11. How Addgene Creates Content

    Type

    Blog Post

    ...final check before publication.   Do research! Nearly everything we write entails a primary literature...

12. Plasmids 101: Screens vs. Selections

    Type

    Blog Post

    ...both a screen and a selection, it is important to clearly define what type of factor you are looking for ...

13. AAV Q&A with Tim Miles

    Type

    Blog Post

    ...Would you recommend any liver specific capsid, particularly one that can target the epithelial cells in ...

14. Hot Plasmids - February 2022

    Type

    Blog Post

    ...create a genome-wide library capable of performing similarly to Cas9 screens in a compacted library. Overall...

15. Antibodies 101: Monoclonal Antibodies

    Type

    Blog Post

    ...for your experiment Monoclonal antibodies are particularly useful when you want to ensure that the antibody...

16. 7 Tips to Secure a STEAM Internship This Summer

    Type

    Blog Post

    ...Addgene blog Check out other tools and resources for early career researchers Applying for jobs? Check out ...

17. A Deep Dive into BioBuilder

    Type

    Blog Post

    ...teacher professional development program that trains nearly 100 teachers each year, with workshops held at ...

18. Enabling Precision Functional Genomics with the Target Accelerator Plasmid Collection

    Type

    Blog Post

    ...PMC5120861. While there is much work to do, these early pilot studies have demonstrated technical feasibility...

19. Addgene’s Viral Service - Why Virus? Why Now?

    Type

    Blog Post

    ...fulfilling our mission for an even bigger impact. In early 2016 we surveyed hundreds of scientists about various...

20. Synthesized by Ginkgo Bioworks, Shared by Addgene: SARS-CoV-2 Plasmids for Many Expression Systems

    Type

    Blog Post

    ... QC process. While this has worked well for the early sets of SARS-CoV-2 materials, it will not scale ...